{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:38:18Z","timestamp":1773283098609,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijantimicag.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T21:58:40Z","timestamp":1525903120000},"page":"836-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cefoxitin-based antibiotic therapy for extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study"],"prefix":"10.1016","volume":"51","author":[{"given":"Elisa","family":"Demonchy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Courjon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Ughetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Risso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolphe","family":"Garraffo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0010","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.clinthera.2015.06.013","article-title":"Assessment of outpatient and inpatient antibiotic treatment patterns and health care costs of patients with complicated urinary tract infections","volume":"37","author":"Turner","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-8-12","article-title":"Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis","volume":"8","author":"Etienne","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jac\/dkh282","article-title":"Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae","volume":"54","author":"Muller","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0030","author":"ECDC"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0040","author":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cid\/cir838","article-title":"Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia","volume":"54","author":"Pulcini","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0055","author":"SFAR"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0070","author":"SPILF"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1592\/phco.28.9.1133","article-title":"Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study","volume":"28","author":"Suffoletta","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0080","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2015.08.011","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?","volume":"39","author":"Pilmis","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0090","first-page":"793","article-title":"Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"47","author":"Kern\u00e9is","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.medmal.2016.04.008","article-title":"Cefoxitin: an alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"46","author":"Mambie","year":"2016","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0100","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1128\/AAC.02509-14","article-title":"Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"58","author":"Guet-Revillet","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0105","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/AAC.14.6.866","article-title":"Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections","volume":"14","author":"Nair","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1179\/joc.2010.22.5.355","article-title":"Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection","volume":"22","author":"Senol","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijantimicag.2016.04.014","article-title":"Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum \u03b2-lactamase urinary tract infections","volume":"48","author":"Veve","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-016-1888-1","article-title":"Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study","volume":"16","author":"Matthews","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0125","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.02611-15","article-title":"Long-term fosfomycin-tromethamine oral therapy for difficult-to-treat chronic bacterial prostatitis","volume":"60","author":"Los-Arcos","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/159.5.1005","article-title":"In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase","volume":"159","author":"Pangon","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.008_bib0135","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T03:12:41Z","timestamp":1529118761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0924857918300116"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefoxitin-based antibiotic therapy for extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}